However, these studies generally agree that there is a consistent association between presence of TMPRSS2-ERG and prostate cancer recurrence [131,152,157] In breast cancer, many gene fusion events have also been identified, with a recent genomic landscape study of adjacent gene rearrangements uncovering 99 recurrent gene fusions [162]. This evidence concerns the gene ERG and prostate carcinoma.